Treatment of Opioid Use Disorder: Opioid Agonist Medications Part II

Presenter: Reka Danko, MD

Online CME Credit

Fee: $15.00

Provides 0.50 hour(s) of CE/CME credit (Presented on June 27, 2019, Reviewed July 1, 2019; Expires July 30, 2023)

Provides CME credit towards the Nevada State Board of Medical Examiners' requirement for 2 hours of training related to the misuse and abuse of controlled substances, the prescribing of opioids, or addiction during each licensure period.

Overview

The purpose of this activity is to introduce clinicians to FDA-approved opioid agonist medications for the treatment of Opioid Use Disorder.

Learning Objectives

Following participation in this course, participants should be able to:

  • Introduce the FDA-approved opioid agonist medications for the treatment of Opioid Use Disorder
  • Detail opioid withdrawal management with buprenorphine and methadone
  • Examine the benefits and risks of buprenorphine and methadone
  • Identify adjunct medications that may assist in opioid withdrawal management
  • Discuss challenges with Medication-Assisted Treatment using agonist medications
  • Provide additional resources for patients and clinicians